Abstract

Disrupted or atypical light–dark cycles disrupts synchronization of endogenous circadian clocks to the external environment; extensive circadian rhythm desynchrony promotes adverse health outcomes. Previous studies suggest that disrupted circadian rhythms promote neuroinflammation and neuronal damage post-ischemia in otherwise healthy mice, however, few studies to date have evaluated these health risks with aging. Because most strokes occur in aged individuals, we sought to identify whether, in addition to being a risk factor for poor ischemic outcome, circadian rhythm disruption can increase risk for vascular cognitive impairment and dementia (VCID). We hypothesized that repeated 6 h phase advances (chronic jet lag; CJL) for 8 weeks alters cerebrovascular architecture leading to increased cognitive impairments in aged mice. Female CJL mice displayed impaired spatial processing during a spontaneous alternation task and reduced acquisition during auditory-cued associative learning. Male CJL mice displayed impaired retention of the auditory-cued associative learning task 24 h following acquisition. CJL increased vascular tortuosity in the isocortex, associated with increased risk for vascular disease. These results demonstrate that CJL increased sex-specific cognitive impairments coinciding with structural changes to vasculature in the brain. We highlight that CJL may accelerate aged-related functional decline and could be a crucial target against disease progression.

Details

Title
Chronic phase advances reduces recognition memory and increases vascular cognitive dementia-like impairments in aged mice
Author
Liu, Jennifer A. 1 ; Bumgarner, Jacob R. 1 ; Walker, William H. 2 ; Meléndez-Fernández, O. Hecmarie 1 ; Walton, James C. 1 ; DeVries, A. Courtney 3 ; Nelson, Randy J. 1 

 West Virginia University, Department of Neuroscience, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140) 
 West Virginia University, Department of Neuroscience, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Medicine, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140) 
 West Virginia University, Department of Neuroscience, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Medicine, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, West Virginia University Cancer Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140) 
Pages
7760
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3030940235
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.